APA (7th ed.) Citation

Bringhen, S., & Goldschmidt, H. (2018). Cardiovascular adverse events in modern myeloma therapy - incidence and risks: A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA). Haematologica, 103(9), . https://doi.org/10.3324/haematol.2018.191288

Chicago Style (17th ed.) Citation

Bringhen, Sara, and Hartmut Goldschmidt. "Cardiovascular Adverse Events in Modern Myeloma Therapy - Incidence and Risks: A Review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)." Haematologica 103, no. 9 (2018). https://doi.org/10.3324/haematol.2018.191288.

MLA (9th ed.) Citation

Bringhen, Sara, and Hartmut Goldschmidt. "Cardiovascular Adverse Events in Modern Myeloma Therapy - Incidence and Risks: A Review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)." Haematologica, vol. 103, no. 9, 2018, https://doi.org/10.3324/haematol.2018.191288.